← Back to Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Industry Overview

Stock Screener

Select filters to narrow down the 8 companies below

8 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

Atyr Pharma Inc

LIFE

Atyr Pharma Inc

LIFE
Market Cap $1.27B
Dividends 0.0%
P/E Ratio -7.6
Revenue $0.00
Net Income -$10.8M -27.5%
Profit Margin
Employees 80
View Stock

Atyr Pharma Inc

ATYR

Atyr Pharma Inc

ATYR
Market Cap $1.27B
Dividends 0.0%
P/E Ratio -0.7
Revenue $0.00
Net Income -$10.8M -27.5%
Profit Margin
Employees 80
View Stock

Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

TECX
Market Cap $648.53M
Dividends 0.0%
P/E Ratio -7.7
Revenue $0.00
Net Income -$25.2M +58.7%
Profit Margin
View Stock

LakeShore Biopharma Co Ltd.

LSB

LakeShore Biopharma Co Ltd.

LSB
Market Cap $25.84M
Dividends 0.0%
P/E Ratio -0.5
Revenue $19M
Net Income -$25.5M
Profit Margin -134.3%
View Stock

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)

LSBPW

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)

LSBPW
Market Cap $25.84M
Dividends 0.0%
P/E Ratio -0.5
Revenue $19M
Net Income -$25.5M
Profit Margin -134.3%
View Stock

Skye Bioscience Inc

SKYE

Skye Bioscience Inc

SKYE
Market Cap $24.25M
Dividends 0.0%
P/E Ratio -0.5
Revenue $0.00
Net Income -$12.5M -99.9%
Profit Margin
Employees 11
View Stock

Entero Therapeutics Inc.

ENTO

Entero Therapeutics Inc.

ENTO
Market Cap $13.58M
Dividends 0.0%
P/E Ratio -1.0
Revenue $38.2k
Net Income -$3.44M +173.0%
Profit Margin -9000.0%
Employees 12
View Stock

COSCIENS Biopharma Inc.

CSCI

COSCIENS Biopharma Inc.

CSCI
Market Cap $8.57M
Dividends 0.0%
P/E Ratio -0.4
Revenue $2.75M +17.6%
Net Income -$2.7M +89.9%
Profit Margin -98.3%
Employees 47
View Stock